about
Revised adult immunization guideline recommended by the korean society of infectious diseases, 2014.Cost-effectiveness of pneumococcal vaccination strategies for the elderly in KoreaInfluenza and Pneumococcal Vaccine Coverage Rates among Patients Admitted to a Teaching Hospital in South Korea.Perception and Attitudes of Korean Obstetricians about Maternal Influenza VaccinationAnalysis of Risk Factors for Severe Acute Respiratory Infection and Pneumonia and among Adult Patients with Acute Respiratory Illness during 2011-2014 Influenza Seasons in Korea.Comparison of immunogenicity and safety of an influenza vaccine administered concomitantly with a 13-valent pneumococcal conjugate vaccine or 23-valent polysaccharide pneumococcal vaccine in the elderly.The Clinical and Experimental Vaccine Research has been selected for coverage in Emerging Sources Citation Index of Web of Science.Acute Myopericarditis caused by Human Metapneumovirus.Viral Shedding and Environmental Cleaning in Middle East Respiratory Syndrome Coronavirus Infection.In vitro Comparison of Anti-Biofilm Effects against Carbapenem-Resistant Acinetobacter baumannii: Imipenem, Colistin, Tigecycline, Rifampicin and Combinations.Hospital-based Influenza Morbidity and Mortality (HIMM) Surveillance for A/H7N9 Influenza Virus Infection in Returning Travelers.Effects of influenza immunization on pneumonia in the elderly.Development of a multiplexed opsonophagocytic killing assay (MOPA) for group B Streptococcus.Incidence and case fatality rates of community-acquired pneumonia and pneumococcal diseases among Korean adults: Catchment population-based analysis.Safety and Effectiveness of Peramivir in Korean Adult Influenza Patients: Prospective Observational Study Based on Post-Marketing Surveillance DataKorea HIV/AIDS Cohort Study: study design and baseline characteristicsImmunogenicity and safety of an egg-based inactivated quadrivalent influenza vaccine (GC3110A) versus two inactivated trivalent influenza vaccines with alternate B strains: A phase Ⅲ randomized clinical trial in adultsA Case of Retinal Vessel Occlusion Caused by Bartonella InfectionEffectiveness of influenza and pneumococcal polysaccharide vaccines against influenza-related outcomes including pneumonia and acute exacerbation of cardiopulmonary diseases: Analysis by dominant viral subtype and vaccine matchingDisease Burden and Etiologic Distribution of Community-Acquired Pneumonia in Adults: Evolving Epidemiology in the Era of Pneumococcal Conjugate VaccinesSpread of ceftriaxone non-susceptible pneumococci in South Korea: Long-term care facilities as a potential reservoirHepatitis A Virus Infection from a Contaminated Tap of Ground Water Facility in a Neighborhood Park, Republic of KoreaProgress toward a group B streptococcal vaccineAge-stratified analysis of serotype-specific baseline immunity against group B streptococcusSignificance of Decreasing Rate of HIV and HBV Co-infection in a Nationwide Korean HIV/AIDS CohortImmunogenicity and safety of 13-valent pneumococcal conjugate vaccine in HIV-infected adults in the era of highly active antiretroviral therapy: analysis stratified by CD4 T-cell countSocial Distancing against COVID-19: Implication for the Control of InfluenzaClinical Significance of a High SARS-CoV-2 Viral Load in the Saliva
P50
Q26821898-75C0D458-7146-4982-911D-2FCB87965304Q33675229-5308E9CA-0A15-416F-A62E-039E2AF1FBECQ35258981-F6FD36C2-9C3A-4B25-9729-3ABE6439F553Q36989767-34351B60-8A44-4C04-A3B6-43BDD4801D3FQ37547829-81813AEC-9E6A-4E5A-9792-BF46A58E244EQ37625249-A82AE186-35AE-433A-9493-DB78BB053935Q38264792-F649ECF3-DCE0-4D44-BA8C-A2A972D3512EQ40305410-F99720FA-D666-4680-BE08-4FB13EBB541CQ40825692-20289CEC-2AC8-4BA4-B95B-58C7AC1B400FQ41354320-3BA5EE7E-694F-491C-AC8A-81B69934B455Q47550009-D7FD2D39-A1B8-4E9C-BFA6-2504B31AA98CQ47581064-1BC001F7-B66B-4CFF-A4FC-D2B4C803CCAEQ48053443-F556EE2A-46EC-451C-ABF0-E89DE1062193Q54245877-43E16CAE-8E88-4D13-B0AC-3B5E8F6E7167Q56890304-869D8A68-AE0F-4A0D-9EB4-E0A13B405C5CQ57215762-5B0ADC91-33A5-426E-B72C-A58AE8E2960CQ58610341-EED97E8A-536C-47DA-8805-5B22E218EB74Q59137291-1AE61159-95CF-40C6-9789-C87F7382F439Q60046341-E1264023-3457-4818-A834-71F55AB4B4B3Q60950047-57633614-65D8-4311-B27C-E2A658DF4850Q61806492-F1250B5A-3BCB-40B0-BD8F-AD4E3AC80FFFQ64088193-4FD1AE3C-504D-47F4-87CF-A7170E54DE40Q89565635-563737EB-A4B0-430C-8AB9-A9DC1BA2C17BQ91117085-16F36B95-8615-47B5-95B7-2DB04B1B9ABAQ92723216-03EAE913-8977-44C1-AA63-95EA7CE903D0Q92811795-2DE9DD44-54D1-4202-AD98-D1AE655CC4B9Q94958599-18200AA2-DEC2-41EC-A4A2-D853BCC4D7FEQ95657532-0D4D4831-9197-415A-A34D-D3F856D4CA2F
P50
description
investigador
@es
researcher
@en
name
Joon Young Song
@en
type
label
Joon Young Song
@en
prefLabel
Joon Young Song
@en
P31
P496
0000-0002-0148-7194